Neal D. Shore,


Medical Director and CPI Carolina Urologic Research Center Managing Partner, Atlantic Urology Clinics
Myrtle Beach, SC

Neal Shore, MD, FACS, is an internationally recognized expert in systemic therapies for patients with advanced Urologic Cancers and innovative therapies to treat patients suffering from prostate enlargement symptoms.

Dr Shore has conducted more than 250 clinical trials, focusing mainly on GU Oncology, and serves on the Executive Boards of: Society of Urologic Oncology Board, Society of Urologic Oncology Clinical Trials Consortium, and the Large Urology Group Practice Association. He also is a member of the AUA Data Committee, the Bladder Cancer Advocacy Think Tank, and the editorial board of Urology Times. He has numerous articles/peer reviewed publications and also performs peer review for more multiple journals. A graduate of Duke University Medical School, Dr Shore completed a 6-month clinical research fellowship in Pretoria, South Africa, and then completed his General Surgery/Urology training at New York Hospital Cornell Medical Center and at Memorial Sloan-Kettering Cancer Center in New York City. He is a Fellow of the American College of Surgeons.


Oncology / Prostate Cancer

Treating Castration-Resistant Disease

expert roundtables by Peter R. Carroll, MD, MPH, E. David Crawford, MD, Leonard Gomella, MD, and Neal D. Shore, MD, FACS

Men with castration-resistant prostate cancer (CRPC) who have no radiological evidence of metastases are, nonetheless, at great risk for developing...READ MORE